• Charles B. Slonim
  • Jay Justin OlderEmail author
  • William P. Mack


Enucleation is performed to remove a blind, painful eye, a severely traumatized eye, or an eye that is thought to harbor a malignancy. The goal of the surgeon is to remove the eye in the most appropriate manner (e.g., remove sufficient optic nerve tissue if an intraocular tumor is present) and to create a socket that will accommodate a properly designed prosthesis. The best possible cosmetic result is achieved in cooperation with an ocularist, but the surgeon must also consider movement of the prosthesis and such potential complications such as extrusion of the implant or a contracted socket. The techniques presented in this chapter are designed to result in a good cosmetic appearance, as well as minimize such postoperative risks as implant extrusion and contracted socket.


Enucleation Prosthesis Extrusion Contracted socket Sizing sphere Non-porous implant Methylmethacrylate Silicone Porous implant Hydroxyapatite Porous polyethylene Bioceramic Motility peg Motility coupling post 

Supplementary material

Video 44.1 Transection of oblique muscles during an enucleation. Courtesy of Richard C. Allen, MD, PhD, FACS. (MPEG 100674 kb)
419986_5_En_44_MOESM2_ESM.mp4 (93.3 mb)
Video 44.2 Implantation of a bio-eye orbital implant. Courtesy of Richard C. Allen, MD, PhD, FACS. (MP4 95527 kb)
419986_5_En_44_MOESM3_ESM.mp4 (201 mb)
Video 44.3 Enucleation with implant. Courtesy of Richard C. Allen, MD, PhD, FACS. (MP4 205843 kb)
419986_5_En_44_MOESM4_ESM.mp4 (211 mb)
Video 44.4 Enucleation medial approach to the optic nerve. Courtesy of Richard C. Allen, MD, PhD, FACS. (MP4 216029 kb)


  1. 1.
    Kaltreider SA, Peake LR, Carter BT. Pediatric enucleation: analysis of volume replacement. Arch Ophthalmol. 2001;119(3):379–84.CrossRefPubMedGoogle Scholar
  2. 2.
    Custer PL, Trinkaus KM. Volumetric determination of enucleation implant size. Am J Ophthalmol. 1999;128:489–94.CrossRefPubMedGoogle Scholar
  3. 3.
    Remulla HD, Rubin PA, Shore JW, Sutula FC, Townsend DJ, Woog JJ, et al. Complications of porous spherical orbital implants. Ophthalmology. 1995;102:586–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Christmas NJ, Gordon CD, Murray TG, Tse D, Johnson T, Garonzik S, O’Brien JM. Intraorbital implants after enucleation and their complications: a 10-year review. Arch Ophthalmol. 1998;116(9):1199–203.CrossRefPubMedGoogle Scholar
  5. 5.
    Jordan DR, Klapper SR, Gilberg SM, Dutton JJ, Wong A, Mawn L. The bioceramic implant: evaluation of implant exposures in 419 implants. Ophthal Plast Reconstr Surg. 2010;26(2):80–2.CrossRefPubMedGoogle Scholar
  6. 6.
    Alwitry A, West S, King J, Foss AJ, Abercrombie LC. Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg. 2007;23(1):11–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Jordan DR, Bawazeer A. Experience with 120 synthetic hydroxyapatite implants (FCI3). Ophthal Plast Reconstr Surg. 2001;17:184–90.CrossRefPubMedGoogle Scholar
  8. 8.
    Jordan DR, Klapper S, Gilberg SM. The use of Vicryl mesh in 200 porous orbital implants: a technique with few exposures. Ophthal Plast Reconstr Surg. 2003;19(1):53–61.CrossRefPubMedGoogle Scholar
  9. 9.
    Karesh JW, Dresner SC. High density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology. 1994;101:1688–96.CrossRefPubMedGoogle Scholar
  10. 10.
    Li T, Shen J, Duffy MT. Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthal Plast Reconstr Surg. 2001;17(6):431–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Martin P, Ghabrial R. Repair of exposed hydroxyapatite orbital implant by a tarsoconjunctival pedicle flap. Ophthalmology. 1998;105(9):1694–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Lin CJ, Liao SL, Jou JR, Kao SC, Hou PK, Chen MS. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86(4):394–6.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Edelstein C, Shields CL, DePotter P, Shields JA. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology. 1997;104(10):1616–21.CrossRefPubMedGoogle Scholar
  14. 14.
    Shoamanesh A, Pang NK, Oestreicher JH. Complications of orbital implants: a review of 542 patients who have undergone orbital implantation and 275 subsequent peg placements. Orbit. 2007;26(3):173–82.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Charles B. Slonim
    • 1
    • 2
    • 3
  • Jay Justin Older
    • 1
    Email author
  • William P. Mack
    • 4
    • 5
  1. 1.Department of OphthalmologyUniversity of South Florida Morsani College of MedicineTampaUSA
  2. 2.Department of Plastic SurgeryUniversity of South Florida Morsani College of MedicineTampaUSA
  3. 3.Department of OphthalmologyUniversity of Florida School of MedicineGainesvilleUSA
  4. 4.Department of OphthalmologyUniversity of South Florida College of MedicineTampaUSA
  5. 5.Mack Center Cosmetic SurgeryTampaUSA

Personalised recommendations